跳至主要内容
临床试验/NCT05939544
NCT05939544已完成不适用

Impact of Short-term Supplementation with a Milk Fat Globule Membrane-enriched Powdered Ingredient on Cardiometabolic and Cognitive Health Outcomes

Loughborough University2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2023年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
2
主要终点
Change-from-baseline in circulating LDL-cholesterol concentrations

研究概览

简要总结

In a randomised, controlled cross-over manner, this trial aims to determine how short-term daily supplementation with a milk fat globule membrane-enriched ingredient impacts on cardiometabolic health and cognitive outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 40 - 70 years
  • BMI: 25-45 kg/m2
  • Recreationally active (> 3 x 30 min moderate exercise per week)
  • Understands and is willing and able to comply with all study procedures, including changes to diet
  • Fluent in written and spoken English
  • Access to, and able to use, the internet/computer/tablet device

排除标准

  • Smoking (including vaping)
  • Unstable weight history (≥3 kg loss or gain in the previous 3 months) or planning or currently on a weight reduction scheme
  • Currently taking part or have participated in another research study in the last two months (e.g., dietary intervention)
  • Diagnosed with cardiovascular disease or suffered myocardial infarction/stroke in the past twelve months
  • Existing or significant past medical history of any medical condition likely to affect the study outcomes.
  • Prescribed medications or supplements likely to interfere with study outcomes or prescribed antibiotics within the last three months
  • Use of antidepressant/anti-anxiety medication if it has changed in the last three months or expected to change within the 3-month study period.
  • Known allergy or intolerance to study food (lactose intolerance, dairy)
  • Being vegan or any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
  • Excessive alcohol consumption: >21 unit/wk
  • Pregnancy, seeking to become pregnant or active lactation

结局指标

主要结局

Change-from-baseline in circulating LDL-cholesterol concentrations

时间窗: 28 days

Assessed following the collection of fasted blood samples before and after each 28-day study period

次要结局

  • Change-from-baseline in glucose concentrations (determined by spectrophotometric assay)(28 days)
  • Change-from-baseline in clinic systolic and diastolic blood pressure (assessed by automated upper arm sphygmomanometer)(28 days)
  • Change-from-baseline in cognitive test performance using a neuropsychological seven-test battery which assesses global and domain specific function, as determined by NeurOn software(28 days)
  • Change-from-baseline in body mass (kg) using standard equipment.(28 days)
  • Change-from-baseline in waist circumference (cm) using standard equipment.(28 days)
  • Change-from-baseline in brain-derived neurotrophic factor concentrations (determined by ELISA)(28 days)
  • Change-from-baseline in interleukin-6 concentrations (determined by ELISA)(28 days)
  • Change-from-baseline in insulin concentrations (determined by ELISA)(28 days)
  • Change-from-baseline in circulating lipid and apolipoprotein concentrations (measured using a spectrophotometric assay or high-throughput 1H-NMR metabolomics platform)(28 days)
  • Change-from-baseline in particle size of lipoprotein subclasses, and concentrations of particles within each subclass by high-throughput 1H-NMR metabolomics platform(28 days)
  • Change-from-baseline in selected gut-related metabolites (for example, trimethylamine N-oxide concentrations determined by mass spectrometry)(28 days)
  • Change-from-baseline in HOMA-IR (calculated as [fasting glucose (mmol/L) × fasting insulin (mIU/L)]/22.5])(28 days)
  • Change-from-baseline in forearm blood flow, as assessed by venous occlusion plethysmography (using applanation tonometry)(28 days)
  • Change-from-baseline in lipopolysaccharide-binding protein concentrations (determined by ELISA)(28 days)
  • Change-from-baseline in arterial stiffness, as assessed by radial pulse wave analysis (using applanation tonometry)(28 days)
  • Change-from-baseline in body fat (%) using standard equipment.(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Oonagh Markey

Principal Investigator

Loughborough University

研究点 (2)

Loading locations...

相似试验

Impact of Milk Fat Globule Membrane Supplementation... | 临床试验